CSL (CSLLY) Stock Forecast & Price Target

$86.20 -0.97 (-1.11%)

As of 01/31/2025 03:58 PM Eastern

CSL - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Strong Buy

Based on 2 Analyst Ratings

Sell
0

Hold
0

Buy
2

Based on 2 Wall Street analysts who have issued ratings for CSL in the last 12 months, the stock has a consensus rating of "Strong Buy." Out of the 2 analysts, 2 have given a strong buy rating for CSLLY.

Consensus Price Target

N/A

Get the Latest News and Ratings for CSLLY and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for CSL and its competitors.

CSLLY Analyst Ratings Over Time

Type	Current Forecast 2/2/24 to 2/1/25	1 Month Ago 1/3/24 to 1/2/25	3 Months Ago 11/4/23 to 11/3/24	1 Year Ago 2/2/23 to 2/2/24
Strong Buy	2 Strong Buy rating(s)	1 Strong Buy rating(s)	1 Strong Buy rating(s)	N/A
Buy	0 Buy rating(s)	0 Buy rating(s)	0 Buy rating(s)	N/A
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	N/A
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	N/A
Consensus Price Target	N/A	N/A	N/A	N/A
Forecasted Upside	N/A	N/A	N/A	N/A
Consensus Rating	Strong Buy	Strong Buy	Strong Buy	N/A

CSLLY Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CSLLY Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

CSL Stock vs. The Competition

Type	CSL	Medical Companies	S&P 500
Consensus Rating Score	4.00	2.81	2.53
Consensus Rating	Strong Buy	Moderate Buy	Moderate Buy
Predicted Upside	N/A	14,833.09% Upside	12.26% Upside
News Sentiment Rating	Neutral News See Recent CSLLY News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date	Details
1/16/2025	The Goldman Sachs Group 2 of 5 stars	D. Thillainathan Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy
8/13/2024	Macquarie 1 of 5 stars	D. Bailey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Saturday at 10:24 AM ET.

Should I Buy CSL Stock? CSLLY Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, January 22, 2025. Please send any questions or comments about these CSL pros and cons to contact@marketbeat.com.

CSL
Bull Case

Here are some ways that investors could benefit from investing in CSL Limited:

CSL Limited has a strong presence in the biopharmaceutical market, with diverse product offerings including plasma products and gene therapies, which are in high demand.
The company has recently announced the lapse of conditional rights to securities, indicating a strategic move that could streamline operations and enhance shareholder value.
CSL Limited operates in multiple international markets, including Australia, the United States, and China, which diversifies its revenue streams and reduces dependency on any single market.
The current stock price reflects a robust performance in the pharmaceutical sector, making it an attractive option for investors looking for growth in this industry.
With segments focused on critical health areas such as iron deficiency and nephrology, CSL Limited is positioned to benefit from increasing global health needs and government contracts for pandemic services.

CSL
Bear Case

Investors should be bearish about investing in CSL Limited for these reasons:

Recent announcements regarding the lapse of conditional securities rights may raise concerns about the company's future financing strategies and potential dilution of shares.
The pharmaceutical industry is highly competitive, and CSL Limited faces challenges from other companies developing similar biopharmaceutical products.
Regulatory hurdles in different countries can impact the speed at which CSL Limited can bring new products to market, potentially affecting revenue growth.
Market volatility can affect stock prices, and any downturn in the global economy could impact CSL Limited's performance and investor confidence.
Investors should consider the risks associated with the biopharmaceutical sector, including the high costs of research and development, which can lead to unpredictable financial outcomes.

CSLLY Forecast - Frequently Asked Questions

: 2 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last year. There are currently 2 strong buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "strong buy" CSLLY shares.
: According to analysts, CSL's stock has a predicted downside of -100.00% based on their 12-month stock forecasts.
: Over the previous 90 days, CSL's stock had 1 upgrade by analysts.
: CSL has been rated by research analysts at The Goldman Sachs Group in the past 90 days.
: Analysts like CSL more than other "medical" companies. The consensus rating for CSL is Strong Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how CSLLY compares to other companies.

Stock Forecasts and Research Tools

Related Companies

Today's Ratings

Top Rated Stocks

More Ratings Tools

This page (OTCMKTS:CSLLY) was last updated on 2/1/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

CSL (CSLLY) Stock Forecast & Price Target